A newly approved diabetes drug from Johnson & Johnson may have the potential to be very profitable, given skyrocketing diabetes rates in the Unites States. But a story on the blog Seeking Alpha cautions investors against being too optimistic, given the disappointing results of other diabetes drugs that have gone on the market.
The story mentions GlaxoSmithKline’s Avandia, which has been linked to increased fatalities from heart disease, and is now ...
continue reading...
Researchers at Brigham and Women’s Hospital out of Boston have announced the results of a new study that suggests moderate doses of Vitamin D may help reduce blood pressure.
A report by NPR says the findings are promising because high blood pressure has some well-established risks, including a potentially doubled risk of heart attack or stroke.
Some blood pressure treatments may carry possible health risks as well. For example, two clinical ...
continue reading...
A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports.
At the conclusion of a non-jury trial, U.S. District Judge Janet Bond Arterton in New Haven, Conn., ruled that Ethicon infringed three U.S. patents for ultrasonic surgical instruments owned by Covidien.
Ethicon recently suffered another multi-million setback, in the form of an $11.1 million jury ...
continue reading...
According to a USA Today story about an ongoing fungal meningitis outbreak, the specialty pharmacy responsible has been flagrantly violating both sanitation standards and the terms of the federal laws permitting it to operate.
But the story characterizes the problem not simply as the practices of a single irresponsible business, but a systemic failing that’s permitted “compounding pharmacies” to operate on a large scale under relatively lax regulatory standards.
And patients ...
continue reading...
The East Montgomery County Observer tells the story of a 27-year-old man with kidney failure, whose quality of life was greatly improved when he began using a portable, in-home dialysis system.
He previously had to make a long drive and arrive at a dialysis center at 5 a.m. in order to finish the 4-hour treatment, then make it to work on time. Doctors told him that routine would be necessary three ...
continue reading...
ABC 30 out of Fresno, Calif., reports on a clinical trial for a new blood pressure treatment called Renal Denervation.
The proposed treatment would target overactive renal nerves, which can cause blood pressure to skyrocket. Renal nerves transmit information from the kidneys to the brain. In Renal Denervation, doctors insert a needle into an artery in the groin near the kidneys and burn the nerves.
The ABC 30 story quotes a ...
continue reading...
